1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow relebactam: new trials by email Literature Review of relebactam trials Research Report on relebactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients Imipenem/Cilastatin/Relebactam 1.25g - Obesity, Critical Illness | Phase 4 | Withdrawn | University of Illinois at Chicago | 2023-01-01 | 2024-11-27 |
Critical Illness (1) · Obesity (1)
University of Illinois at Chicago (1)
United States (1)